Author: Grace Khombe (Grace Khombe)

Post

NAC CALLS FOR MULTISECTORAL UNITY IN MOBILIZING DOMESTIC FINANCING OF THE NATIONAL HIV AND AIDS RESPONSE

Let’s join hands to mobilize domestic funding towards national response to HIV and AIDS programming amidst dwindling global resources for external financing. The National AIDS Commission Chief executive officer Dr. Beatrice Matanje made the call on Tuesday 19th August 2025, during orientation of executive members of the Malawi HIV and AIDS Partnership Forum (MPF).  Dr....

Post

Exciting News! Malawi hits the 95:95:95 HIV Targets ahead of the Deadline

Exciting news to share! Over the years, Malawi has registered remarkable strides in the fight against HIV and AIDS since the first case was reported in 1985. NAC Chief executive Officer, Dr. Beatrice Matanje has attributed this to strong political will, community leadership, and the unwavering support of partners. Dr. Matanje proudly mentioned that Malawi...

HIV Long term injectable drug approved!  The National AIDS Commission appeals for continued adherence to present PrEP.
Post

HIV Long term injectable drug approved!  The National AIDS Commission appeals for continued adherence to present PrEP.

Exciting news! The United States Food and Drug Administration (FDA) has approved an injectable drug for HIV prevention called Lenacapavir (LEN) as Pre-Exposure Prophylaxis. The drug needs to be injected just twice a year for the HIV Negative at-risk population groups. The approval means the drug could be rolled out globally to help overcome barriers...

The UNAIDS Joint Programme Plan for Malawi 2025-2030 unveiled; experts say time to review commitment to scale the gains.
Post

The UNAIDS Joint Programme Plan for Malawi 2025-2030 unveiled; experts say time to review commitment to scale the gains.

The UNAIDS Joint Programme Plan for Malawi for 2025-2030 has been unveiled. The program focuses on ending AIDS as a public health threat by 2030. This program builds upon the National Strategic Plan for HIV and AIDS (2023-2025) and aims to accelerate progress towards the 95-95-95 targets, ensuring that most people living with HIV know...